Ann: DEP outperforms leading treatments in ovarian cancer model, page-13

I would expect some honesty in announcements marked as price sensitive to the market.

Not some fluffed up load of garbage that is then indemnified by a coverall disclaimer.

I admit I have been hoodwinked by SPL and some other (over positive) posters here on HC, as have a lot of other long term holders I would think.

I am treating this company as my lesson learned, and I would hate others on here to fall into the same traps as I did.

There are still posters on this forum to date that will post anything to buoy the SP of this company. I intend to remain on here and do my best to provide a balanced opinion on the company (based on FACTS) and call out when anyone is blatantly ramping or otherwise.

If anyone does not like this, then put me on ignore.